23Andme End Period Cash Flow vs Investments Analysis

ME Stock

USD 3.11 0.12 3.72%

23Andme Holding financial indicator trend analysis is way more than just evaluating 23Andme Holding prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether 23Andme Holding is a good investment. Please check the relationship between 23Andme Holding End Period Cash Flow and its Investments accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in 23Andme Holding Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

End Period Cash Flow vs Investments

End Period Cash Flow vs Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of 23Andme Holding End Period Cash Flow account and Investments. At this time, the significance of the direction appears to have pay attention.

The correlation between 23Andme Holding's End Period Cash Flow and Investments is -0.73. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Investments in the same time period over historical financial statements of 23Andme Holding Co, assuming nothing else is changed. The correlation between historical values of 23Andme Holding's End Period Cash Flow and Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of 23Andme Holding Co are associated (or correlated) with its Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Investments has no effect on the direction of End Period Cash Flow i.e., 23Andme Holding's End Period Cash Flow and Investments go up and down completely randomly.

Correlation Coefficient

-0.73

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

End Period Cash Flow

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Most indicators from 23Andme Holding's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into 23Andme Holding current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in 23Andme Holding Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

At present, 23Andme Holding's Sales General And Administrative To Revenue is projected to increase slightly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 5.1 B, whereas Issuance Of Capital Stock is forecasted to decline to 0.00.

	2021	2022	2023	2024 (projected)
Gross Profit	132.9M	134.5M	99.4M	107.2M
Total Revenue	271.9M	299.5M	219.6M	237.5M

Gross Profit Total Revenue

23Andme Holding fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Property Plant Equipment	Short Long Term Debt Total	Current Deferred Revenue
Total Assets		0.1	0.24	0.81	-0.07	0.49	-0.05	-0.55	0.02	0.34	0.74	0.81	-0.03	0.4	0.74	-0.23	-0.18	-0.07	0.58	0.24	-0.35	0.7	0.5	-0.22	-0.05	-0.28
Other Current Liab	0.1		0.95	0.12	0.94	-0.59	0.92	-0.83	0.78	0.91	0.67	-0.34	-0.99	0.36	0.67	0.77	0.85	0.69	0.82	-0.81	-0.04	0.71	-0.72	0.85	0.5	0.8
Total Current Liabilities	0.24	0.95		0.29	0.92	-0.53	0.9	-0.91	0.84	0.94	0.78	-0.11	-0.94	0.55	0.78	0.64	0.85	0.76	0.88	-0.76	-0.16	0.82	-0.59	0.82	0.62	0.81
Total Stockholder Equity	0.81	0.12	0.29		0.04	0.56	-0.09	-0.44	-0.08	0.3	0.56	0.71	-0.05	0.21	0.56	0.0	-0.01	0.34	0.4	0.22	-0.82	0.54	0.52	-0.25	-0.22	-0.18
Other Liab	-0.07	0.94	0.92	0.04		-0.73	0.96	-0.72	0.86	0.86	0.53	-0.44	-0.96	0.4	0.53	0.78	0.97	0.82	0.7	-0.93	-0.07	0.59	-0.81	0.93	0.59	0.93
Net Tangible Assets	0.49	-0.59	-0.53	0.56	-0.73		-0.82	0.29	-0.84	-0.43	-0.1	0.61	0.63	-0.45	-0.1	-0.39	-0.79	-0.4	-0.33	0.88	-0.49	-0.15	0.94	-0.91	-0.79	-0.89
Property Plant And Equipment Net	-0.05	0.92	0.9	-0.09	0.96	-0.82		-0.74	0.95	0.86	0.58	-0.42	-0.93	0.52	0.58	0.66	0.94	0.66	0.75	-0.95	0.16	0.62	-0.86	0.98	0.72	0.93
Net Debt	-0.55	-0.83	-0.91	-0.44	-0.72	0.29	-0.74		-0.73	-0.94	-0.96	-0.17	0.81	-0.6	-0.96	-0.43	-0.6	-0.53	-0.96	0.53	0.11	-0.98	0.32	-0.63	-0.55	-0.57
Retained Earnings	0.02	0.78	0.84	-0.08	0.86	-0.84	0.95	-0.73		0.77	0.6	-0.22	-0.8	0.74	0.6	0.4	0.86	0.56	0.75	-0.88	0.24	0.64	-0.77	0.95	0.89	0.92
Accounts Payable	0.34	0.91	0.94	0.3	0.86	-0.43	0.86	-0.94	0.77		0.86	-0.13	-0.92	0.43	0.86	0.68	0.75	0.65	0.88	-0.71	-0.1	0.89	-0.52	0.76	0.49	0.7
Cash	0.74	0.67	0.78	0.56	0.53	-0.1	0.58	-0.96	0.6	0.86		0.37	-0.64	0.61	1.0	0.25	0.4	0.36	0.94	-0.34	-0.13	1.0	-0.1	0.44	0.45	0.37
Non Current Assets Total	0.81	-0.34	-0.11	0.71	-0.44	0.61	-0.42	-0.17	-0.22	-0.13	0.37		0.4	0.42	0.37	-0.67	-0.47	-0.24	0.19	0.58	-0.34	0.32	0.76	-0.51	-0.05	-0.47
Non Currrent Assets Other	-0.03	-0.99	-0.94	-0.05	-0.96	0.63	-0.93	0.81	-0.8	-0.92	-0.64	0.4		-0.34	-0.64	-0.8	-0.87	-0.7	-0.79	0.84	0.0	-0.69	0.75	-0.88	-0.53	-0.83
Other Assets	0.4	0.36	0.55	0.21	0.4	-0.45	0.52	-0.6	0.74	0.43	0.61	0.42	-0.34		0.61	-0.24	0.42	0.22	0.67	-0.39	0.15	0.6	-0.24	0.5	0.85	0.51
Cash And Short Term Investments	0.74	0.67	0.78	0.56	0.53	-0.1	0.58	-0.96	0.6	0.86	1.0	0.37	-0.64	0.61		0.25	0.4	0.36	0.94	-0.34	-0.13	1.0	-0.1	0.44	0.45	0.37
Net Receivables	-0.23	0.77	0.64	0.0	0.78	-0.39	0.66	-0.43	0.4	0.68	0.25	-0.67	-0.8	-0.24	0.25		0.73	0.72	0.35	-0.69	-0.24	0.31	-0.63	0.62	0.02	0.6
Common Stock Shares Outstanding	-0.18	0.85	0.85	-0.01	0.97	-0.79	0.94	-0.6	0.86	0.75	0.4	-0.47	-0.87	0.42	0.4	0.73		0.84	0.58	-0.96	-0.09	0.46	-0.84	0.93	0.61	0.96
Inventory	-0.07	0.69	0.76	0.34	0.82	-0.4	0.66	-0.53	0.56	0.65	0.36	-0.24	-0.7	0.22	0.36	0.72	0.84		0.42	-0.66	-0.56	0.41	-0.47	0.62	0.32	0.75
Other Current Assets	0.58	0.82	0.88	0.4	0.7	-0.33	0.75	-0.96	0.75	0.88	0.94	0.19	-0.79	0.67	0.94	0.35	0.58	0.42		-0.55	-0.02	0.95	-0.37	0.63	0.56	0.54
Other Stockholder Equity	0.24	-0.81	-0.76	0.22	-0.93	0.88	-0.95	0.53	-0.88	-0.71	-0.34	0.58	0.84	-0.39	-0.34	-0.69	-0.96	-0.66	-0.55		-0.15	-0.4	0.93	-0.96	-0.63	-0.93
Total Liab	-0.35	-0.04	-0.16	-0.82	-0.07	-0.49	0.16	0.11	0.24	-0.1	-0.13	-0.34	0.0	0.15	-0.13	-0.24	-0.09	-0.56	-0.02	-0.15		-0.14	-0.39	0.27	0.42	0.11
Total Current Assets	0.7	0.71	0.82	0.54	0.59	-0.15	0.62	-0.98	0.64	0.89	1.0	0.32	-0.69	0.6	1.0	0.31	0.46	0.41	0.95	-0.4	-0.14		-0.16	0.49	0.47	0.42
Intangible Assets	0.5	-0.72	-0.59	0.52	-0.81	0.94	-0.86	0.32	-0.77	-0.52	-0.1	0.76	0.75	-0.24	-0.1	-0.63	-0.84	-0.47	-0.37	0.93	-0.39	-0.16		-0.92	-0.59	-0.87
Property Plant Equipment	-0.22	0.85	0.82	-0.25	0.93	-0.91	0.98	-0.63	0.95	0.76	0.44	-0.51	-0.88	0.5	0.44	0.62	0.93	0.62	0.63	-0.96	0.27	0.49	-0.92		0.78	0.97
Short Long Term Debt Total	-0.05	0.5	0.62	-0.22	0.59	-0.79	0.72	-0.55	0.89	0.49	0.45	-0.05	-0.53	0.85	0.45	0.02	0.61	0.32	0.56	-0.63	0.42	0.47	-0.59	0.78		0.78
Current Deferred Revenue	-0.28	0.8	0.81	-0.18	0.93	-0.89	0.93	-0.57	0.92	0.7	0.37	-0.47	-0.83	0.51	0.37	0.6	0.96	0.75	0.54	-0.93	0.11	0.42	-0.87	0.97	0.78

Click cells to compare fundamentals

23Andme Holding Account Relationship Matchups

23Andme Holding fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	404.6M	452.1M	1.2B	942.6M	395.2M	741.3M
Other Current Liab	34.7M	31.6M	34.8M	57.5M	32.5M	44.3M
Total Current Liabilities	139.4M	121.6M	153.2M	149.4M	127.3M	117.1M
Total Stockholder Equity	134.2M	(595.6M)	915.7M	713.9M	188.5M	306.3M
Net Tangible Assets	(626.3M)	(602.5M)	480.4M	301.0M	346.2M	363.5M
Property Plant And Equipment Net	137.6M	124.0M	105.4M	94.7M	77.2M	95.0M
Net Debt	(119.0M)	(188.8M)	(466.9M)	(301.5M)	(140.0M)	(147.0M)
Retained Earnings	(793.6M)	(977.2M)	(1.2B)	(1.5B)	(2.2B)	(2.1B)
Accounts Payable	13.1M	12.3M	37.9M	12.9M	11.6M	17.8M
Cash	209.3M	282.5M	553.2M	386.8M	217.9M	280.3M
Non Current Assets Total	158.8M	138.5M	550.3M	517.6M	144.6M	137.4M
Non Currrent Assets Other	7.9M	7.6M	9.6M	10.0M	6.7M	7.0M
Other Assets	9.1M	8.5M	10.4M	10.8M	1.0	0.95
Cash And Short Term Investments	209.3M	282.5M	553.2M	386.8M	217.9M	280.3M
Net Receivables	6.4M	2.5M	3.4M	1.9M	9.1M	9.5M
Liabilities And Stockholders Equity	404.6M	452.1M	1.2B	942.6M	395.2M	741.3M
Inventory	14.1M	6.2M	10.8M	10.2M	12.5M	9.0M
Other Current Assets	16.0M	22.4M	34.4M	32.5M	11.1M	20.4M
Other Stockholder Equity	172.7M	1.2B	2.1B	2.2B	2.4B	1.5B
Total Liab	270.4M	1.0B	236.4M	228.7M	206.6M	316.4M
Total Current Assets	245.9M	313.6M	601.8M	425.0M	250.5M	313.4M
Intangible Assets	5.4M	6.9M	83.5M	61.2M	53.8M	38.7M
Property Plant Equipment	137.6M	123.2M	49.9M	38.6M	34.7M	33.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

How To Invest In 23Andme

Details

Is 23Andme Stock a good investment?

Details

What is 23Andme Holding's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in 23Andme Holding Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 23Andme Holding. If investors know 23Andme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 23Andme Holding listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(122.52)

Revenue Per Share

8.224

Quarterly Revenue Growth

(0.34)

Return On Assets

(0.26)

Return On Equity

(1.54)

The market value of 23Andme Holding is measured differently than its book value, which is the value of 23Andme that is recorded on the company's balance sheet. Investors also form their own opinion of 23Andme Holding's value that differs from its market value or its book value, called intrinsic value, which is 23Andme Holding's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 23Andme Holding's market value can be influenced by many factors that don't directly affect 23Andme Holding's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between 23Andme Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if 23Andme Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 23Andme Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

23Andme End Period Cash Flow vs Investments Analysis

End Period Cash Flow vs Investments

End Period Cash Flow vs Investments Correlation Analysis

Correlation Coefficient

End Period Cash Flow

Investments

23Andme Holding fundamental ratios Correlations

23Andme Holding Account Relationship Matchups

High Positive Relationship

High Negative Relationship

23Andme Holding fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Property Plant Equipment	+ 0.98	Property Plant And Equipment Net
Common Stock Shares Outstanding	+ 0.97	Other Liab
Current Deferred Revenue	+ 0.97	Property Plant Equipment

Non Currrent Assets Other	- 0.99	Other Current Liab
Total Current Assets	- 0.98	Net Debt
Property Plant Equipment	- 0.96	Other Stockholder Equity
Other Stockholder Equity	- 0.96	Common Stock Shares Outstanding
Other Current Assets	- 0.96	Net Debt
Cash And Short Term Investments	- 0.96	Net Debt